Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Obsidian Therapeutics
Over the past year LXRX returned −22.0% and OBX returned −21.7%; their daily moves had a correlation of 0.40.
LXRX −22.0% OBX −21.7%Growth of $1, one year, split-adjusted
| Metric | LXRX | OBX |
|---|---|---|
| Price | $1.56 | $13.93 |
| Market cap | $694.1M | $860.5M |
| Today | −1.27% | +5.13% |
| 1 month | −28.4% | −18.1% |
| 6 months | −14.3% | — |
| Year to date | +35.7% | — |
| 1 year | +2.6% | — |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 16.8× | — |
| Net cash | $139.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 53.3% | — |
| Short % of float | 11.4% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).